Mitochondrial DNA Heteroplasmy Analysis for Sample Identity Verification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Next-generation sequencing (NGS) studies face challenges in accurately identifying sample mislabeling and contamination, which can lead to false results and reduced data quality due to the complexity of sample identity errors, especially in large-scale biological and biomedical research.
Innovation Solution
The method involves performing nucleic acid sequencing assays to obtain mitochondrial DNA (mtDNA) sequencing reads, identifying heteroplasmies and homoplasmies, and assigning primary and secondary mtDNA haplogroups to detect mislabeled or contaminated samples by comparing haplogroup assignments and heteroplasmy frequencies across biological samples from the same individual.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If next-generation sequencing is performed on large batches of DNA or RNA samples, then sequencing throughput and productivity are improved, but sample identity errors and contamination rates increase
Solution Approach 1:
The method performs preliminary identification of sample identity using mitochondrial DNA heteroplasmy patterns before downstream analysis. By assigning haplogroups and detecting heteroplasmy in early processing stages, the system proactively identifies mislabeled or contaminated samples, preventing erroneous results in subsequent high-throughput sequencing analyses.
2Measurement precision
If mitochondrial DNA heteroplasmy analysis is performed to identify sample mislabeling and contamination, then sample identification accuracy is improved, but sequencing data processing complexity increases
Solution Approach 1:
The method extracts and focuses analysis on mitochondrial DNA sequences specifically, separating this critical identification marker from the rest of the genomic data. By isolating mtDNA heteroplasmy patterns as the key diagnostic feature, the system simplifies the overall data processing workflow while maintaining high identification accuracy, avoiding the need to analyze entire genomes for sample verification.
Solution Approach 2:
The method applies specialized analysis protocols specifically to mitochondrial DNA regions, using heteroplasmy detection and haplogroup assignment tailored for mtDNA characteristics. This localized approach optimizes the analysis for sample identification purposes without requiring complex processing of all genomic data, thereby reducing overall computational complexity while maintaining precision.
3Reliability
If strict quality control measures are implemented to detect sample errors, then data reliability is improved, but processing time and computational resources increase
Solution Approach 1:
The method performs partial sequencing focused specifically on mitochondrial DNA regions rather than complete genome sequencing for quality control purposes. By targeting only the essential heteroplasmy-containing mtDNA segments, the system achieves sufficient quality control and sample identification without the time cost of analyzing entire genomes, thus balancing reliability with processing efficiency.
Data Source
AI summary
The present disclosure provides methods of identifying unreliable biological samples that may be mislabeled or contaminated, by determining the heteroplasmy and homoplasmy of mitochondrial DNA present in the biological samples.